Akt |
Protein kinase B |
Ala-Pro |
Alanyl-proline |
ATM |
Mutated in ataxia telangiectasia |
ATR |
ATM and RAD3-related |
BAX |
Bcl-2-associated X |
BCL-2 |
B-cell lymphoma 2 |
cGMP |
Cyclic guanosine monophosphate |
CHK1 |
Checkpoint kinase 1 |
CHK2 |
Checkpoint kinase 2 |
EGF |
Epidermal growth factor |
EP |
Enoxaparin |
ErbB1/EGFR |
Epidermal growth factor receptor |
ErbB2/HER2 |
Epidermal growth factor receptor 2 |
ErbB3 |
Epidermal growth factor receptor 3 |
ECM |
Extracellular matrix |
FAK |
Focal adhesion kinase |
Glut-1 |
Focal adhesion kinase |
Gly |
Glycine |
Gly-Pro |
Glycyl-proline |
Grb2 |
Growth factor receptor-bound protein 2 |
HB-EGF |
Heparin-binding EGF-like growth factor |
HIF-1α |
Hypoxia-inducible factor 1 alpha |
Hyp |
Hydroxyproline |
IFNAR1 |
Interferon alpha/beta receptor 1 |
IGF-1R |
Insulin-like growth factor 1 receptor |
iNOS |
Inducible nitric oxide synthase |
IκBα |
Nuclear factor kappa alpha |
JAK |
Janus kinase |
Kd
|
Dissociation constant |
Leu-Pro |
Leucyl-proline |
MAPK/ERK |
MAP kinase/Extracellular signal-regulated kinase |
MDM2 |
Murine double minute 2 |
MDM4 |
Murine double minute 4 |
Met-Pro |
Methionyl-proline |
mTOR |
Mammalian target of rapamycin |
NADPH |
Reduced nicotinamide adenine dinucleotide phosphate |
NADP+ |
Nicotinamide adenine dinucleotide phosphate |
NADH |
Reduced nicotinamide adenine dinucleotide |
NAD+ |
Nicotinamide adenine dinucleotide |
NF-κβ |
Nuclear factor kappa beta |
NMDA |
N-methyl-D-aspartate |
NO |
Nitric oxide |
NS5 |
Non-structural protein 5 |
NSAID |
Nonsteroidal anti-inflammatory drug |
OATT |
Ornithine aminotransferase |
P5C |
Pyrroline-5-carboxylic acid |
P5CS |
Pyrroline-5-carboxylic acid synthase |
PD |
Prolidase deficiency |
PEPD |
Prolidase |
Phe-Pro |
Phenylalanyl-proline |
PI3K |
Phosphoinositide 3-kinase |
PPA |
Plasma prolidase activity |
Pro |
Proline |
PRODH/POX |
Proline dehydrogenase/proline oxidase |
PYCR1/2/L |
Pyrroline-5-carboxylic acid reductase 1/2/L |
ROS |
Reactive oxygen species |
SNP |
Single nucleotide polymorphism |
Src |
Proto-oncogene tyrosine-protein kinase |
STAT3 |
Signal transducer and activator of transcription 3 |
T2D |
Type 2 diabetes |
TGF-β |
Transforming growth factor beta |
TGF-β1R |
Transforming growth factor beta 1 receptor |
Val-Pro |
Valyl-proline |
VEGF |
Vascular endothelial growth factor |
VHL |
Von Hippel–Lindau tumor suppressor |
WIP1 |
Wild-type p53-induced phosphatase |